EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure

Gabriel Chan, Caleb Fisher, Ian C Baldwin, Stephen Joseph Warrillow, Anis Chaba, Rinaldo Bellomo, Ary Serpa Neto

Blood Purification · 2025

DOI: 10.1159/000548502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2025. Verfasst von Gabriel Chan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Acetaminophen, Continuous Renal Replacement Therapy, Phosphates, Liver Failure, Acute. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypophosphataemia is common in acute liver failure (ALF) and may worsen during continuous renal replacement therapy (CRRT) with phosphate-free fluids. We aimed to evaluate the safety and efficacy of Phoxilium®, a phosphate-containing CRRT fluid.

Methods

We conducted a retrospective single-center cohort study of paracetamol-induced ALF patients treated with CRRT between January 2018 and May 2024 as our ICU transitioned from Accusol® to Phoxilium®. We obtained data on demographics, biochemistry, and outcomes. We compared biochemical variables every 6 h up to 48 h post-CRRT initiation and then every 12 h until 168 h. The primary outcome was the occurrence of severe hypophosphataemia (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenContinuous Renal Replacement TherapyPhosphatesLiver Failure, AcuteHypophosphatemiaHumansMaleFemaleRetrospective StudiesMiddle AgedAdultAged

Stichwörter der Autor:innen

Acute liver failureContinuous renal replacement therapyHypophosphataemiaParacetamol-induced acute liver failurePhoxilium

Substanzen

AcetaminophenPhosphates

Autor:innen und Institutionen

  • Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
  • School of Nursing and Health Sciences, RMIT University, Melbourne, Victoria, Australia.
  • Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.
  • Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia, ary.serpaneto@monash.edu.
  • Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia, ary.serpaneto@monash.edu.

Zitieren

APA

Chan, G., Fisher, C., Baldwin, I. C., Warrillow, S. J., Chaba, A., Bellomo, R., & Serpa Neto, A. (2025). Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure. Blood Purification. https://doi.org/10.1159/000548502

Vancouver

Chan G, Fisher C, Baldwin IC, Warrillow SJ, Chaba A, Bellomo R, et al. Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure. Blood Purification. 2025. doi:10.1159/000548502

BibTeX
@article{Chan2025,
  author = {Chan, Gabriel and Fisher, Caleb and Baldwin, Ian C and Warrillow, Stephen Joseph and Chaba, Anis and Bellomo, Rinaldo and Serpa Neto, Ary},
  title = {Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure},
  journal = {Blood Purification},
  year = {2025},
  doi = {10.1159/000548502}
}
Kostenlos starten →